On May 10, 2023, PharmaCyte Biotech, Inc., closed the transaction. The company has raised a total of $35 million in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | +1.90% | -3.15% | -0.46% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.46% | 17.84M | |
+26.03% | 661B | |
+26.74% | 566B | |
-6.66% | 352B | |
+19.35% | 332B | |
+3.36% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.23% | 145B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. announced that it has received $35 million in funding